BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao J, Li H, Zhao S, Wang E, Zhu J, Feng D, Zhu Y, Dou W, Fan Q, Hu J, Jia L, Liu L. Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling. Mol Cancer 2021;20:46. [PMID: 33658044 DOI: 10.1186/s12943-021-01343-5] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
Number Citing Articles
1 Dai W, Duan Y, Yuan W, Wang S. circTUBGCP5 promotes liver cancer progression and glycolysis by up-regulating the expression of ACSL4. Appl Biol Chem 2022;65. [DOI: 10.1186/s13765-022-00723-9] [Reference Citation Analysis]
2 Cheng K, Cai N, Zhu J, Yang X, Liang H, Zhang W. Tumor-associated macrophages in liver cancer: From mechanisms to therapy. Cancer Commun (Lond) 2022. [PMID: 36069342 DOI: 10.1002/cac2.12345] [Reference Citation Analysis]
3 German B, Ellis L. Polycomb Directed Cell Fate Decisions in Development and Cancer. Epigenomes 2022;6:28. [DOI: 10.3390/epigenomes6030028] [Reference Citation Analysis]
4 Zhou Y, Liu F, Ma C, Cheng Q. Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma. J Clin Lab Anal 2022;:e24673. [PMID: 36036748 DOI: 10.1002/jcla.24673] [Reference Citation Analysis]
5 Wang S, Liu G, Li Y, Pan Y. Metabolic Reprogramming Induces Macrophage Polarization in the Tumor Microenvironment. Front Immunol 2022;13:840029. [DOI: 10.3389/fimmu.2022.840029] [Reference Citation Analysis]
6 Deng Y, Xiao M, Wan AH, Li J, Sun L, Liang H, Wang QP, Yin S, Bu X, Wan G. RNA and RNA Derivatives: Light and Dark Sides in Cancer Immunotherapy. Antioxid Redox Signal 2022. [PMID: 35369726 DOI: 10.1089/ars.2022.0035] [Reference Citation Analysis]
7 Xing H, Gao M, Wang Y, Zhang X, Shi J, Wang X, Liu X, Ma Q, Kong X, Yang C, Ding J, Meng L. Genome-wide gain-of-function screening identifies EZH2 mediating resistance to PI3Kα inhibitors in oesophageal squamous cell carcinoma. Clin Transl Med 2022;12:e835. [PMID: 35604910 DOI: 10.1002/ctm2.835] [Reference Citation Analysis]
8 Hillyar CR, Kanabar SS, Rallis KS, Varghese JS. Complex cross-talk between EZH2 and miRNAs confers hallmark characteristics and shapes the tumor microenvironment. Epigenomics 2022. [PMID: 35574589 DOI: 10.2217/epi-2021-0534] [Reference Citation Analysis]
9 Xue C, Gu X, Bao Z, Su Y, Lu J, Li L. The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment. Front Immunol 2022;13:847728. [PMID: 35281015 DOI: 10.3389/fimmu.2022.847728] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Mirzaei S, Gholami MH, Hushmandi K, Hashemi F, Zabolian A, Canadas I, Zarrabi A, Nabavi N, Aref AR, Crea F, Wang Y, Ashrafizadeh M, Kumar AP. The long and short non-coding RNAs modulating EZH2 signaling in cancer. J Hematol Oncol 2022;15:18. [PMID: 35236381 DOI: 10.1186/s13045-022-01235-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
11 Sun S, Yu F, Xu D, Zheng H, Li M. EZH2, a prominent orchestrator of genetic and epigenetic regulation of solid tumor microenvironment and immunotherapy. Biochim Biophys Acta Rev Cancer 2022;:188700. [PMID: 35217116 DOI: 10.1016/j.bbcan.2022.188700] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
12 Smith CM, Hutvagner G. A comparative analysis of single cell small RNA sequencing data reveals heterogeneous isomiR expression and regulation. Sci Rep 2022;12:2834. [PMID: 35181712 DOI: 10.1038/s41598-022-06876-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang C, Ma C, Gong L, Guo Y, Fu K, Zhang Y, Zhou H, Li Y. Macrophage Polarization and Its Role in Liver Disease. Front Immunol 2021;12:803037. [PMID: 34970275 DOI: 10.3389/fimmu.2021.803037] [Reference Citation Analysis]
14 Lu W, Bai L, Chen Y. The Role of Macrophage-Derived Exosomes in Liver Diseases. Infectious Diseases & Immunity 2022;2:34-41. [DOI: 10.1097/id9.0000000000000034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Pu J, Li W, Wang A, Zhang Y, Qin Z, Xu Z, Wang J, Lu Y, Tang Q, Wei H. Long non-coding RNA HOMER3-AS1 drives hepatocellular carcinoma progression via modulating the behaviors of both tumor cells and macrophages. Cell Death Dis 2021;12:1103. [PMID: 34815380 DOI: 10.1038/s41419-021-04309-z] [Reference Citation Analysis]
16 Zhang H, Sun L, Hu X. Macrophages M1-Related Prognostic Signature in Hepatocellular Carcinoma. J Oncol 2021;2021:6347592. [PMID: 34745260 DOI: 10.1155/2021/6347592] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Peng Z, Zhang Y, Shi D, Jia Y, Shi H, Liu H. miR-497-5p/SALL4 axis promotes stemness phenotype of choriocarcinoma and forms a feedback loop with DNMT-mediated epigenetic regulation. Cell Death Dis 2021;12:1046. [PMID: 34732693 DOI: 10.1038/s41419-021-04315-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ji LY, Wei M, Liu YY, Di ZL, Li SZ. miR‑497/MIR497HG inhibits glioma cell proliferation by targeting CCNE1 and the miR‑588/TUSC1 axis. Oncol Rep 2021;46:255. [PMID: 34664678 DOI: 10.3892/or.2021.8206] [Reference Citation Analysis]
19 He Y, de Araújo Júnior RF, Cruz LJ, Eich C. Functionalized Nanoparticles Targeting Tumor-Associated Macrophages as Cancer Therapy. Pharmaceutics 2021;13:1670. [PMID: 34683963 DOI: 10.3390/pharmaceutics13101670] [Reference Citation Analysis]
20 Ahmad A. Epigenetic regulation of immunosuppressive tumor-associated macrophages through dysregulated microRNAs. Semin Cell Dev Biol 2021:S1084-9521(21)00236-6. [PMID: 34556420 DOI: 10.1016/j.semcdb.2021.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
21 Huang Z, Su G, Bi X, Zhang L, Xu Z, Wang G. Over-expression of long non-coding RNA insulin-like growth factor 2-antisense suppressed hepatocellular carcinoma cell proliferation and metastasis by regulating the microRNA-520h/cyclin-dependent kinase inhibitor 1A signaling pathway. Bioengineered 2021;12:6952-66. [PMID: 34516353 DOI: 10.1080/21655979.2021.1975016] [Reference Citation Analysis]